Elizabeth La, PhD

GSK

Poster(s):

• (250) Characteristics associated with RSV vaccination among adults aged 60 years and older in the United States between August 2023–February 2025
  Wednesday, October 29, 2025

• (258) Public health impact of increasing RSV vaccination uptake among US adults aged ≥60 years: A modeling analysis based on real-world uptake data through February 2025
  Wednesday, October 29, 2025